| CONTRACTED-THIRD-PARTY-PAYORS |
CONTRACTED-THIRD-PARTY-PAYORS |
90%
|
Contracted third-party payors 13 % 12 % |
| HEALTHCARE-INSTITUTIONS |
HEALTHCARE-INSTITUTIONS |
90%
|
Customer A Healthcare institutions 12 % 15 % |
| UNH |
UnitedHealth Group Incorporated |
85%
|
years, cyber-attacks and other cyber incidents have become more prevalent and much harder to detect and defend against. These cyber-attacks and other incidents include unauthorized access to our netw… |
| UNH |
UnitedHealth Group Incorporated |
85%
|
Reciprocal relationship from UNH graph: Reciprocal relationship from IRTC graph: years, cyber-attacks and other cyber incidents have become more prevalent and much harder to detect and defend against… |
| BARDY-DIAGNOSTICS-INC |
BARDY-DIAGNOSTICS-INC |
62%
|
e licensed technology were $ 17.0 million. Contingent consideration liabilities were $ 20.7 million and $ 20.4 million as of March 31, 2026, and December 31, 2025, respectively, and were included in … |
| BAX |
Baxter International Inc. |
62%
|
Reciprocal relationship from BAX graph: Reciprocal relationship from IRTC graph: Reciprocal relationship from BAX graph: Reciprocal relationship from IRTC graph: e licensed technology were $ 17.0 mil… |
| BAXTER-INTERNATIONAL-INC |
BAXTER-INTERNATIONAL-INC |
62%
|
e licensed technology were $ 17.0 million. Contingent consideration liabilities were $ 20.7 million and $ 20.4 million as of March 31, 2026, and December 31, 2025, respectively, and were included in … |
| BOSTON-SCIENTIFIC-INC |
BOSTON-SCIENTIFIC-INC |
62%
|
care Inc. and Welch Allyn. Additional competitors, such as BioTelemetry, Inc. (now part of Royal Philips), Preventice Solutions, Inc. (now part of Boston Scientific, Inc.), and BardyDx manufacture re… |
| BSX |
Boston Scientific Corporation |
62%
|
Reciprocal relationship from BSX graph: Reciprocal relationship from IRTC graph: Reciprocal relationship from BSX graph: Reciprocal relationship from IRTC graph: Reciprocal relationship from BSX grap… |
| CGS-ADMINISTRATORS-LLC |
CGS-ADMINISTRATORS-LLC |
62%
|
ators’ disagreement with our interpretation of the regulations as applied to indirect tests, such as the iRhythm Services, could result in the discontinuation of our reimbursement under the Medicare … |
| COORDINATION-GROUP |
COORDINATION-GROUP |
62%
|
Coordination Group. Additional EU and UK legislative developments, including product cybersecurity rules and evolving device software requirements, may impose further security-by-design, vulnerabilit… |
| DELAWARE-GENERAL-CORPORATION |
DELAWARE-GENERAL-CORPORATION |
62%
|
s, complaints, or regulatory investigations or fines, and if we are otherwise unable to transfer personal data between and among countries and regions in which we operate, it could affect the manner … |
| GE-HEALTHCARE-PHILIPS-HEALTHCARE-MORTARA-INSTRUM |
GE-HEALTHCARE-PHILIPS-HEALTHCARE-MORTARA-INSTRUM |
62%
|
ators’ disagreement with our interpretation of the regulations as applied to indirect tests, such as the iRhythm Services, could result in the discontinuation of our reimbursement under the Medicare … |
| HILL-ROM-HOLDINGS-INC |
HILL-ROM-HOLDINGS-INC |
62%
|
e licensed technology were $ 17.0 million. Contingent consideration liabilities were $ 20.7 million and $ 20.4 million as of March 31, 2026, and December 31, 2025, respectively, and were included in … |
| HOLDING-COMPANY-TRANSACTION-THE-HOLDING-COMPANY |
HOLDING-COMPANY-TRANSACTION-THE-HOLDING-COMPANY |
62%
|
company (“VLS”) and Verily Ireland Limited (“VIL” and together with VLS, “Verily”) (such Development Collaboration Agreement, as amended by Amendment No. 1 dated April 26, 2021 and Amendment No. 2 da… |
| INDENTURE-THE-HOLDING-COMPANY |
INDENTURE-THE-HOLDING-COMPANY |
62%
|
company (“VLS”) and Verily Ireland Limited (“VIL” and together with VLS, “Verily”) (such Development Collaboration Agreement, as amended by Amendment No. 1 dated April 26, 2021 and Amendment No. 2 da… |
| LTCM-MERGER-SUB-INC |
LTCM-MERGER-SUB-INC |
62%
|
orporated in the state of Delaware in September 2006. On January 12, 2026, iRhythm Technologies, Inc. implemented a corporate holding company structure that resulted in the formation of a new parent … |
| MEDICAL-DEVICE-COORDINATION-GROUP |
MEDICAL-DEVICE-COORDINATION-GROUP |
62%
|
rs of security measures and monitoring to protect the confidentiality, integrity, and availability of this data and the systems and devices that store and transmit such data. Despite our security mea… |
| PHG |
Koninklijke Philips N.V. |
62%
|
Reciprocal relationship from PHG graph: Reciprocal relationship from IRTC graph: care Inc. and Welch Allyn. Additional competitors, such as BioTelemetry, Inc. (now part of Royal Philips), Preventice … |
| ROYAL-PHILIPS-PREVENTICE-SOLUTIONS-INC |
ROYAL-PHILIPS-PREVENTICE-SOLUTIONS-INC |
62%
|
care Inc. and Welch Allyn. Additional competitors, such as BioTelemetry, Inc. (now part of Royal Philips), Preventice Solutions, Inc. (now part of Boston Scientific, Inc.), and BardyDx manufacture re… |
| SPACELABS-HEALTHCARE-INC |
SPACELABS-HEALTHCARE-INC |
62%
|
ators’ disagreement with our interpretation of the regulations as applied to indirect tests, such as the iRhythm Services, could result in the discontinuation of our reimbursement under the Medicare … |
| VERILY-IRELAND-LIMITED |
VERILY-IRELAND-LIMITED |
62%
|
company (“VLS”) and Verily Ireland Limited (“VIL” and together with VLS, “Verily”) (such Development Collaboration Agreement, as amended by Amendment No. 1 dated April 26, 2021 and Amendment No. 2 da… |
| WAL |
Western Alliance Bancorporation |
62%
|
Reciprocal relationship from WAL graph: Reciprocal relationship from IRTC graph: Reciprocal relationship from WAL graph: Reciprocal relationship from IRTC graph: Reciprocal relationship from WAL grap… |
| WELCH-ALLYN-INC |
WELCH-ALLYN-INC |
62%
|
e licensed technology were $ 17.0 million. Contingent consideration liabilities were $ 20.7 million and $ 20.4 million as of March 31, 2026, and December 31, 2025, respectively, and were included in … |
